ReviewGlia2026
Glia Are Bussin': How Single-Cell and Spatial Transcriptomics Enlighten the Role of Neuroglia in Spinal Cord Injury and Regeneration.
Review in Glia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Ferroptosis-Pyroptosis Crosstalk in Spinal Cord Injury: Molecular Mechanisms, Emerging Connectors, and Staged Therapeutic Perspectives.Journal of molecular neuroscience : MN · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
The impact that single-cell and spatial genomic technologies have had on the scientific community since their advent has been widespread and profound. The field of spinal cord injury (SCI) is one such area that has experienced an increased implementation of genomic technologies within recent years. Innovative genomic tools have proven to be particularly useful for delving into the progression of SCI pathology and plasticity that is highly dynamic, temporal, and involves the close coordination and signaling of many different central nervous system resident and non-resident cells. Neuroglia, in particular, have been extensively profiled, resulting in a deeper understanding of how neuroglia phenotypes and molecular signaling interact and progress after a spinal cord injury. In this review, we summarize some of the major discoveries that have enlightened and/or shifted our current understanding of the role of neuroglia in injury potentiation and repair. Additionally, through a meta-analysis of five SCI single-cell time course atlases, we uncover insights and cautions regarding how injury model, time course, sample preparation, cellular categorization, and analytical approach impact the interpretation of any new genomic research in this field.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.